U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07090330) titled 'ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis' on July 21.
Brief Summary: This is a multicenter, randomized, double-blinded, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Plaque Psoriasis
Intervention:
DRUG: ORKA-001 Induction Dose
ORKA-001 Induction Dose, administered by subcutaneous (SC) injection
OTHER: Placebo
Placebo administered by subcutaneous (SC) injection
DRUG: ORKA-001 Mainten...